Raymond James analyst William Wallace downgrades CapStar Finl Hldgs (NASDAQ:CSTR) from Outperform to Market Perform.
Hologic Stock Falls After Q3 Revenue Dip, But It Lifts Revenue and Profit Outlook
Hologic Inc (NASDAQ: HOLX) posted Q3 adjusted EPS of $0.93, down from $0.95 a year ago and beating the consensus of $0.88